ImmunoGen’s Elahere Wins Big In Confirmatory Ovarian Cancer Trial

 
• By Alaric DeArment
ImmunoGen announced data from the Phase III MIRASOL trial of Elahere in ovarian cancer • Source: Shutterstock

More from Clinical Trials

More from R&D